Litigation Details for LEO Pharma A/S v. Perrigo UK Finco Limited Partnership (D. Del. 2017)
✉ Email this page to a colleague
LEO Pharma A/S v. Perrigo UK Finco Limited Partnership (D. Del. 2017)
| Docket | ⤷ Sign Up | Date Filed | 2017-12-06 |
| Court | District Court, D. Delaware | Date Terminated | 2018-04-09 |
| Cause | 35:0145 | Assigned To | Joseph F. Bataillon |
| Jury Demand | None | Referred To | Sherry R. Fallon |
| Patents | 8,278,292; 9,820,959; 9,833,428; 9,833,429 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in LEO Pharma A/S v. Perrigo UK Finco Limited Partnership
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for LEO Pharma A/S v. Perrigo UK Finco Limited Partnership (D. Del. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 0000-00-00 | 1 | of U.S. Patent No. 9,820,959 (“the ’959 Patent”), U.S. Patent No. 9,833,428 (“the ’428 Patent”), and …and U.S. Patent No. 9,833,429 (“the ’429 Patent”) (collectively, “the Patents-in-Suit”). 14. …Related LEO Patents and other U.S. patents owned by LEO, and Perrigo contends that such patents are unenforceable…infringe on such patents. 38. The Patents-in-Suit are continuations of patents among the Related… This is a civil action for patent infringement arising under the patent laws of the United States, | External link to document | |
| 0000-00-00 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,820,959 B2; 9,833,428 B2; 9,833,429…2017 9 April 2018 1:17-cv-01753 835 Patent - Abbreviated New Drug Application(ANDA) | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
